Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Celadon Pharmaceuticals Plc - London-based manufacturer and supplier of cannabinoid-based medicines formerly known as Summerway Capital PLC - Posts widened loss in the 16 months ended December 31. Loss grows to £720,369 from £174,511 in the year ended August 31, 2020. The firm had unaudited cash of £12.1 million as of April 22. Cash and cash equivalents fall to £4.5 million from £5.5 million.
Current stock price: 115.55 pence, untraded
12-month change: down 42%
Copyright 2022 Alliance News Limited. All Rights Reserved.